| Dr Heidi Enejosa Rodillo, MD | |
|
901 W Greenwood St Ste 1, Abbeville, SC 29620-5727 | |
| (864) 366-9681 | |
| (864) 366-5600 |
| Full Name | Dr Heidi Enejosa Rodillo |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 53 Years |
| Location | 901 W Greenwood St Ste 1, Abbeville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124194451 | NPI | - | NPPES |
| 582366449 | Other | TAX ID | |
| 11698 | Other | SC | SC LICENSE NUMBER |
| PC3126 | Medicaid | SC | |
| 080085988 | Other | SC | MEDICARE RAILROAD |
| 116984 | Medicaid | SC | |
| RHC210 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 11698 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Health Related Home Care | Abbeville, SC | Home health agency |
| Abbeville Area Medical Center | Abbeville, SC | Hospital |
| Self Regional Healthcare | Greenwood, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abbeville County Memorial Hospital | 7719891506 | 26 |
News Archive
The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
As Hurricane Ivan pummels the U.S. Gulf Coast, Saint Louis University continues to study what we need to do to ensure Grandma's safety in case of a disaster.
› Verified 9 days ago
| Entity Name | Abbeville County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649816216 PECOS PAC ID: 7719891506 Enrollment ID: O20031117000214 |
News Archive
The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
As Hurricane Ivan pummels the U.S. Gulf Coast, Saint Louis University continues to study what we need to do to ensure Grandma's safety in case of a disaster.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heidi Enejosa Rodillo, MD Po Box 968, Abbeville, SC 29620-0968 Ph: (864) 366-9681 | Dr Heidi Enejosa Rodillo, MD 901 W Greenwood St Ste 1, Abbeville, SC 29620-5727 Ph: (864) 366-9681 |
News Archive
The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
As Hurricane Ivan pummels the U.S. Gulf Coast, Saint Louis University continues to study what we need to do to ensure Grandma's safety in case of a disaster.
› Verified 9 days ago